Cyclo Therapeutics- Warrants (14/11/2025) Overview

Cyclo Therapeutics- Warrants (14/11/2025) Research & Development

Research & Development expenses for CYTHW.

Quarterly R&D Expenses

$5.49M

↑ 58.34% YoY

As of Sep 30, 2024

Annual R&D Expenses (TTM)

$15.97M

↑ 20.81% YoY

Trailing 12 months ending Sep 30, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin